Some components of the cardiac β-adrenergic system are altered in the chronic indeterminate form of experimental Trypanosoma cruzi infection

International Journal for Parasitology

Volumn 38, Issue 13, 2008, Pages 1481-1492

  Silvina Lo Presti, M ^a,b   Walter Rivarola, H ^a,b   Bustamante, Juan Manuel ^a   Fernández, Alicia R ^a   Enders, Julio E ^a   Levin, Gloria ^c   Juaneda, Ernesto ^d   Fretes, Ricardo ^a   Fernanda Triquell, M ^a   Paglini Oliva, Patricia A ^a,b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Universidad Nacional de La Rioja   (Argentina)

^c HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^d Instituto Oulton ^*  (Argentina)

Author keywords

Adrenergic signal transduction system; Cardiac contractility; Chronic indeterminate Chagas' disease; Myocardiopathy; Physiopathology; Trypanosoma cruzi strains

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP;

CARDIOVASCULAR SYSTEM; IMMUNOASSAY; PROTOZOAN; TRYPANOSOMIASIS;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; IN VIVO STUDY; LIGAND BINDING; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; CHAGAS CARDIOMYOPATHY; CYCLIC AMP; ELECTROCARDIOGRAPHY; EPINEPHRINE; HEART; HUMANS; MICE; MYOCARDIAL CONTRACTION; MYOCARDIUM; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 53049107856     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2008.04.009     Document Type: Article

References (37)

1. Barki-Harrington L., Perrino C., and Rockman H.A. Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc. Res. 63 (2004) 391-402
2. Bohm M., Flesch M., and Scgnabel P. Role of G-proteins in altered β-adrenergic responsiveness in the failing and hypertrophied myocardium. Basic Res. Cardiol. 91 Suppl. 2 (1996) 47-51
3. Brodde O.E., Bruck H., and Leineweber K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J. Pharmacol. Sci. 100 (2006) 323-337
4. Bustamante J., Rivarola H.W., Fernandez A.R., Enders J., Fretes R., Palma J.A., and Paglini-Oliva P. Indeterminate Chagas disease: Trypanosoma cruzi strain and reinfections are factors involved in the progression of cardiopathy. Clin. Sci. 104 (2003) 415-420
5. Bustamante J.M., Rivarola H.W., Fernández A.R., Enders J., Fretes R., De Luca D'Oro G., Palma J.A., and Paglini-Oliva P. Trypanosoma cruzi reinfections provoke synergistic effect and cardiac β-adrenergic receptors' dysfunction in the acute phase of experimental Chagas' disease. Exp. Parasitol. 103 (2003) 136-142
6. Caforio A.L., Mahon N.J., Tona F., and McKenna W.J. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur. J. Heart Fail. 4 (2002) 411-417
7. Chakraborti S., Chakraborti T., and Shaw G. β-adrenergic mechanisms in cardiac diseases. A perspective. Cell Signal. 12 (2000) 499-513
8. 2-mucarinic cholinergic receptors without requiring receptor cross-linking. J. Neuroimmunol. 153 (2004) 99-107
9. Dávila D.F., Rossell O., and Arata de Bellabarba G. Pathogenesis of chronic Chagas' heart disease: parasite persistence and autoimmune response versus cardiac remodelling and neurohormonal activation. Int. J. Parasitol. 32 (2002) 107-109
10. Ding B., Abe J., Wei H., Huang Q., Walsh R.A., Molina C.A., Zhao A., Sadoshima J., Blaxall B.C., Berk B.C., and Yan C. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis implications in heart failure. Circulation 111 (2005) 2469-2476
11. Dzimiri N. Regulation of β-adrenoceptor signalling in cardiac function and disease. Pharmacol. Rev. 51 (1999) 465-501
12. Elizari M.B. Chagasic myocardiopathy. Historical prospective. Medicina (Buenos Aires) 59 (1999) 25-40
13. Enders J.E., Fernández A.R., Rivarola H.W., Paglini P.A., and Palma J.A. Studies of membrane fluidity and heart contractile force in Trypanosoma cruzi infected mice. Mem. Inst. Oswaldo Cruz 99 (2004) 691-696
14. Esposito G., Rapacciuolo A., Naga Prasad A.V., and Rockman H.A. Cardiac hypertrophy: role of G protein-coupled receptors. J. Card. Fail. 8 (2002) S409-S414
15. Fernández A.R., Paglini-Oliva P., Palma J.A., and Lacuara J.L. Isometric developed tension and histopathology of myocardium of chagasic mice I. Acta Physiol. Pharmacol. Ther. Lat. 41 (1991) 397-404
16. Gilman A. Regulations of adenylyl cyclase by G proteins. In: Nishizuka Y. (Ed). The Biology and Medicine of Signal Transduction (1990), Raven Press, New York 51-57
17. Hagemann D., and Xiao R.P. Dual site phospholamban phosphorylation and its physiological relevance in the heart. Trends Cardiovasc. Med. 12 (2002) 51-56
18. 1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J. Am. Coll. Cardiol. 36 (2000) 1280-1287
19. 1-adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc. Med. 16 (2006) 20-24
20. Kamp T.J., and Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ. Res. 87 (2000) 1095-1102
21. Leff P. The two-state model of receptor activation. Trends Pharmacol. Sci. 16 (1995) 89-97
22. Lefkowitz R.J., Samama P., Cotecchia S., and Costa T. Constitutive activity of receptors coupled to guanine-nucleotide regulatory proteins. Trends Pharmacol. Sci. 14 (1993) 303-308
23. Lehnart S.E., Wehrens X.H.T., Reiken S., Warrier S., Belevych A.E., Harvey R.D., Richter W., Jin S.L.C., Conti M., and Marks A.R. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123 (2005) 25-35
24. Lo Presti M.S., Bustamante J.M., Rivarola H.W., Fernández A.R., Enders J., Fretes R., Levin G., and Paglini-Oliva P.A. Changes in the cardiac beta-adrenergic system provoked by different T. cruzi strains. Int. J. Cardiol. 111 (2006) 104-112
25. Lopez Bergami P., Scaglione J., and Levin M.J. Antibodies against carboxy-terminal end of the Trypanosoma cruzi ribosomal P protein are pathogenic. FEBS J. 15 (2001) 2602-2612
26. Macêdo V. Indeterminate form of Chagas disease. Mem. Inst. Oswaldo Cruz. 94 Suppl. I (1999) 311-316
27. 1 adrenergic receptor. Eur. J. Immunol. 31 (2001) 2210-2216
28. Milligan G., Bond R.A., and Lee M. Inverse agonism, pharmacological curiosity or potential therapeutic strategy. Trends Pharmacol. Sci. 16 (1995) 10-13
29. Movsesian M.A., and Bristow M.R. Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. Curr. Top. Dev. Biol. 68 (2005) 25-48
30. Ribeiro A.L., and Rocha M.O. Indeterminate form of Chagas disease: considerations about diagnosis and prognosis. Rev. Soc. Bras. Med. Trop. 31 (1998) 301-314
31. Rose N.R. Infection, mimics and auto-immune disease. J. Clin. Invest. 107 (2001) 943-944
32. Sterin-Borda L., Giordanengo L., Joensen L., and Gea S. Cruzipain induces autoantibodies against cardiac acetylcholine receptors functional and pathological implications. Eur. J. Immunol. 33 (2003) 2459-2468
33. Sterin-Borda L., Gorelik G., Postan M., Gonzalez Cappa S., and Borda E. Alterations in cardiac β-adrenergic receptors in chagasic mice and their association with circulating beta-adrenoceptor-related autoantibodies. Cardiovasc. Res. 41 (1999) 116-125
34. Taniwaki N.N., Machado F.S., Massensini A.R., and Mortara R.A. Trypanosoma cruzi disrupts myofibrillar organization and intracellular calcium levels in mouse neonatal cardiomyocytes. Cell Tissue Res. 324 (2006) 489-496
35. Viladarga J.P., Steinmeyer R., Harms G.S., and Lohse M.J. Molecular basis of inverse agonism in a G protein-coupled receptor. Nat. Chem. Biol. 1 (2005) 25-28
36. Wallukat G., Nissen E., Morvinski R., and Müller J. Autoantibodies against the β and muscarinic receptors in cardiomyopathy. Herz 25 (2000) 261-266
37. World Health Organization, 2002. Control of Chagas Disease. Second Report of the WHO Expert Committee. WHO Technical Report Series, No 905. World Health Organization, Geneva.